Regulatory News:
Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO)
Under the liquidity contract entered into between Valerio Therapeutics and Kepler Cheuvreux, the following resources appeared on the liquidity account on December 31st 2023:
368,174 shares
- 144,918.05
Number of executions on buy side on semester: 324
- Number of executions on sell side on semester: 244
- Traded volume on buy side on semester: 304,205 shares for 69,976.87
- Traded volume on sell side on semester: 223,191 shares for 56,117.81
As a reminder
- the following resources appeared on the last half year statement on 30 June 2023 on the liquidity account:
287,160 shares
- 156,554.06
Number of executions on buy side on semester: 509
- Number of executions on sell side on semester: 492
- Traded volume on buy side on semester: 634,648 shares for 258,705.74
- Traded volume on sell side on semester: 923,185 shares for 402,719.91
- the following resources appeared on the liquidity account when the activity started:
87,612 shares
- 196,423.24
The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240131554337/en/
Contacts:
Valerio Therapeutics S.A.
